P53 Status Influences the Anti-proliferative Effect Induced by IFITM1 Inhibition in Estrogen Receptor-positive Breast Cancer Cells.
DER Sheng SunJung-Sook YoonYong-Seok KimHye Sung Won
Published in: Cancer genomics & proteomics (2024)
IFITM1 inhibition may enhance the sensitivity to tamoxifen based on p53-dependent enhancement of IFN signaling in wild-type p53, ER-positive breast cancer cells.